designing first-in-human trials for small molecules and biologics
Published 3 years ago • 10K plays • Length 37:34Download video MP4
Download video MP3
Similar videos
-
31:53
getting to first-in-human for small molecules and biologics
-
36:56
fda’s clinical regulatory perspective: designing first-in-human trial for cellular and gene therapy
-
9:53
complex innovative trial designs pilot meeting program: the process
-
1:02:19
chemistry and manufacturing requirements for early clinical development: what’s in there? prove it.
-
54:28
overview of non-clinical assessment in drug development (8/14) redi 2017
-
18:21
assembling the best team to navigate through preclinical development
-
29:20
fda oncology drug development overview – past to present
-
1:02:30
ai for pharmacological modeling
-
56:31
cmc considerations for biotechnology product development: a regulatory perspective
-
47:00
stem cell clinical trials: designing preclinical studies for first in human trials | joy cavagnaro
-
6:04:12
redi annual conference 2024: cber (biologics) innovation in medical product development (day 1 of 2)
-
47:38
winship grand rounds september 13, 2017: r. donald harvey, pharmd
-
4:09
oncology therapy development workshop overview, day two
-
2:08:12
clinical investigator training course (citc) update - scientific updates part 2
-
15:50
oncology center of excellence introduction and overview of the oncology therapy development workshop
-
1:10:23
fda clinical investigator training course (citc) 2022, day 1 – part 3
-
46:11
clinical development of radiopharmaceuticals a theranostic pairs and dosimetry considerations
-
26:05
the finalized bioanalytical method validation guidance: what’s new for ndas and blas – june 17, 2019
-
24:38
clinical trial design & development of highly targeted agents in the molecular era